These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7830288)

  • 1. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
    Sato T; Lochry EA; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (3)--Perinatal and postnatal study in rats with intraperitoneal administration].
    Sato T; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():233-47. PubMed ID: 7830289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam(1)--Fertility and general reproduction study in rats with intraperitoneal administration].
    Sato T; Lochry EA; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():199-24. PubMed ID: 7830287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A six-month intraperitoneal repeated dose toxicity study of tazobactam/piperacillin and tazobactam in rats].
    Hayashi T; Yada H; Auletta CS; Daly IW; Knezevich AL; Cockrell BY
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():155-76. PubMed ID: 7830285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A six-month intravenous repeated dose toxicity study of tazobactam/piperacillin and tazobactam in dogs].
    Hayashi T; Yada H; Blair M; Laughlin KA; Blanchard GL; Tucek PC; Geil RG
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():177-97. PubMed ID: 7830286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-dose toxicity studies of tazobactam/piperacillin and tazobactam].
    Hayashi T; Yada H; Anai M; Umano T; Kawazu K; Anai S; Kaziwara T; Yamasaki K
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():145-53. PubMed ID: 7830284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Takemoto M; Matsuo K; Oguro M; Kouchi Y
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
    Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
    Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
    Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
    Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
    Iwai N; Nakamura H; Miyazu M
    Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
    Kuno K; Ogawa A; Hayakawa F; Miyajima Y; Takahashi H; Okumura A; Kato T; Itomi K
    Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients].
    Waga S; Yokoyama M; Tsushima T; Chiba C; Saito T; Okamoto T; Asuka T; Kitazawa J; Tateyama N; Sato Y; Takahashi Y
    Jpn J Antibiot; 1998 May; 51(5):305-18. PubMed ID: 9693964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transferability of tazobactam/piperacillin (TAZ/PIPC) to cerebrospinal fluid of rabbit with meningitis caused by Staphylococcus aureus].
    Haruta T; Nishio T; Kobayashi Y
    Jpn J Antibiot; 1998 Jun; 51(6):432-6. PubMed ID: 9755832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
    Nishida K; Higashitani F; Hyodo A
    Chemotherapy; 1997; 43(3):171-8. PubMed ID: 9142457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
    Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
    Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
    Nishida K; Niidome K; Hashimoto M; Otsuki M; Nishino T
    Jpn J Antibiot; 1994 Oct; 47(10):1348-62. PubMed ID: 7807695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.
    Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Aug; 51(4):473-477. PubMed ID: 28690028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.